Ane Ogbe
- Virology top 5%
- HIV Research and Treatment 7
-
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 7
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS Research and Interventions 3
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 2
-
- CAR-T cell therapy research 2
- Co-authors
- John FraterEleanor BarnesPaul KlenermanSusanna DunachieSam M. MurrayM. Azim AnsariAlistair L. J. SymondsRandeep Singh
- Journals
- Frontiers in Immunology (4 papers)Frontiers in Cellular and Infection Microbiology (1 paper)Scientific Reports (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Ane Ogbe
15 papers receiving 335 citations
Peers
Comparison fields: 5 of 61
- Virology 98
- Immunology 188
- Infectious Diseases 117
- Modeling and Simulation 9
- Animal Science and Zoology 16
Countries citing papers authored by Ane Ogbe
This map shows the geographic impact of Ane Ogbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ane Ogbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ane Ogbe more than expected).
Fields of papers citing papers by Ane Ogbe
This network shows the impact of papers produced by Ane Ogbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ane Ogbe. The network helps show where Ane Ogbe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ane Ogbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 6 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 93 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 28 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 8 | |
| 12 | 2020 | 9 | |
| 13 | 2017 | 46 | |
| 14 | 2016 | 0 | |
| 15 | 2016 | 75 | |
| 16 | 2015 | 25 |
About Ane Ogbe
Ane Ogbe is a scholar working on Virology, Immunology, Infectious Diseases, Modeling and Simulation and Microbiology, having authored 16 papers that have together received 337 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), HIV Research and Treatment (7 papers), T-cell and B-cell Immunology (7 papers), SARS-CoV-2 and COVID-19 Research (3 papers), HIV/AIDS Research and Interventions (3 papers), CAR-T cell therapy research (2 papers), COVID-19 Clinical Research Studies (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (98 citations), Immunology (188 citations), Infectious Diseases (117 citations), Modeling and Simulation (9 citations) and Animal Science and Zoology (16 citations). Ane Ogbe has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include John Frater, Eleanor Barnes, Paul Klenerman, Susanna Dunachie, Sam M. Murray, M. Azim Ansari, Alistair L. J. Symonds, Randeep Singh, Suling Li and Tizong Miao. Their work appears in journals such as Frontiers in Immunology, Frontiers in Cellular and Infection Microbiology, Scientific Reports, Nature reviews. Immunology and Immunology and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.